| Trial Identifier: | 218407 |
| Sponsor: | GlaxoSmithKline |
| Collaborator: |
Not applicable
|
| Start Date: | July 2022 |
| Primary Completion Date: | July 2023 |
| Study Completion Date: | July 2023 |
| Condition: | COVID-19 Immunisation |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| United Kingdom | Birmingham, United Kingdom, B15 2GW |
| United Kingdom | Cambridge, United Kingdom, CB2 0QQ |
| United Kingdom | Cardiff, United Kingdom, CF14 4XW |
| United Kingdom | London, United Kingdom, NW1 2BU |
| United Kingdom | London, United Kingdom, SE1 7EH |
| United Kingdom | Middlesbrough, United Kingdom, TS4 3BW |
| United Kingdom | NEWCASTLE UPON TYNE, United Kingdom, NE1 4LP |
| United Kingdom | Plymouth, United Kingdom, PL6 5FP |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company